Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
J Clin Invest ; 123(6): 2719-29, 2013 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-23676464

RESUMO

Adult-onset autosomal-dominant leukodystrophy (ADLD) is a progressive and fatal neurological disorder characterized by early autonomic dysfunction, cognitive impairment, pyramidal tract and cerebellar dysfunction, and white matter loss in the central nervous system. ADLD is caused by duplication of the LMNB1 gene, which results in increased lamin B1 transcripts and protein expression. How duplication of LMNB1 leads to myelin defects is unknown. To address this question, we developed a mouse model of ADLD that overexpresses lamin B1. These mice exhibited cognitive impairment and epilepsy, followed by age-dependent motor deficits. Selective overexpression of lamin B1 in oligodendrocytes also resulted in marked motor deficits and myelin defects, suggesting these deficits are cell autonomous. Proteomic and genome-wide transcriptome studies indicated that lamin B1 overexpression is associated with downregulation of proteolipid protein, a highly abundant myelin sheath component that was previously linked to another myelin-related disorder, Pelizaeus-Merzbacher disease. Furthermore, we found that lamin B1 overexpression leads to reduced occupancy of Yin Yang 1 transcription factor at the promoter region of proteolipid protein. These studies identify a mechanism by which lamin B1 overexpression mediates oligodendrocyte cell-autonomous neuropathology in ADLD and implicate lamin B1 as an important regulator of myelin formation and maintenance during aging.


Assuntos
Lamina Tipo B/metabolismo , Oligodendroglia/patologia , Doença de Pelizaeus-Merzbacher/metabolismo , Animais , Axônios/metabolismo , Axônios/patologia , Modelos Animais de Doenças , Marcha Atáxica/metabolismo , Marcha Atáxica/patologia , Marcha Atáxica/fisiopatologia , Predisposição Genética para Doença , Humanos , Lamina Tipo B/genética , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Transgênicos , Atividade Motora , Proteína Proteolipídica de Mielina/genética , Bainha de Mielina/metabolismo , Bainha de Mielina/patologia , Oligodendroglia/metabolismo , Doença de Pelizaeus-Merzbacher/patologia , Doença de Pelizaeus-Merzbacher/fisiopatologia , Regiões Promotoras Genéticas , Ligação Proteica , Teste de Desempenho do Rota-Rod , Convulsões/metabolismo , Convulsões/patologia , Convulsões/fisiopatologia , Fator de Transcrição YY1/metabolismo
2.
Acta Neurol Scand ; 100(6): 369-76, 1999 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-10589796

RESUMO

OBJECTIVE: To investigate the possible abnormal regional brain metabolism during ataxic gait in olivopontocerebellar atrophy (OPCA), and to evaluate the response of the cerebellar subregions to instability during bipedal gait. MATERIAL AND METHODS: On 9 patients with OPCA in early phase and on 10 age-matched normal subjects, we performed positron emission tomography (PET) with 2-[18F]fluoro-2-deoxy-D-glucose (FDG) under two different conditions: supine resting and 30 min treadmill walking. RESULTS: Both in normals and in patients with OPCA, the FDG uptake in the walking state (Uwalk) was significantly greater than that in the resting state (Urest) in the pyramis, declive-folium-tuber and culmen of the cerebellar vermis, and in the thalamus. In the patients, the Uwalk was also significantly greater than the Urest in the posterior lobe of cerebellar hemisphere and in the pons and midbrain. In the pyramis, the activation ratio (= Uwalk/Urest) of the patients was significantly lower than that of the normals. CONCLUSIONS: We considered that these findings reflect the pathophysiology of ataxic gait in OPCA patients and the compensatory mechanism for the instability during ataxic gait.


Assuntos
Cerebelo/metabolismo , Marcha Atáxica/metabolismo , Atrofias Olivopontocerebelares/metabolismo , Tomografia Computadorizada de Emissão , Adulto , Estudos de Casos e Controles , Cerebelo/diagnóstico por imagem , Teste de Esforço , Feminino , Fluordesoxiglucose F18 , Marcha Atáxica/diagnóstico por imagem , Marcha Atáxica/etiologia , Humanos , Masculino , Pessoa de Meia-Idade , Atrofias Olivopontocerebelares/complicações , Atrofias Olivopontocerebelares/diagnóstico por imagem , Compostos Radiofarmacêuticos , Tálamo/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA